Latham & Watkins Advises WestView Capital Partners on Investment in Helio Health Group

Helio Health Group, LLC, a specialized expert‑driven artificial intelligence (AI) company focused on the life sciences industry, today announced that it has received a strategic minority investment from WestView Capital Partners, a Boston‑based growth equity firm focused exclusively on partnering with middle‑market growth companies.

Latham & Watkins LLP represented WestView Capital Partners in the transaction with a corporate deal team led by Boston partner Nate Amory, with associates Jennifer Boyd and Gordon Wilford. Advice was also provided on tax matters by Bay Area partner Grace Lee; on benefits matters by Boston partner Josh Friedman, with associate Rebecca Fishbein; on intellectual property matters by Boston partner Deborah Hinck, with associate Susana Santos; on data privacy and cybersecurity matters by Bay Area partner Heather Deixler, with associate Chad Leiper; and on healthcare regulatory matters by Los Angeles partner Jennifer Yoo.